USS Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $30.9M | Buy |
221,598
+8,786
| +4% | +$1.23M | 0.12% | 92 |
|
|
2025
Q4 | $26.1M | Hold |
212,812
| – | – | 0.12% | 103 |
|
|
2025
Q3 | $23.6M | Hold |
212,812
| – | – | 0.11% | 108 |
|
|
2025
Q2 | $23.6M | Sell |
212,812
-3,172
| -1% | -$338K | 0.14% | 93 |
|
|
2025
Q1 | $24.2M | Sell |
215,984
-78
| -0% | -$8.05K | 0.18% | 85 |
|
|
2024
Q4 | $20M | Sell |
216,062
-28,606
| -12% | -$2.58M | 0.14% | 122 |
|
|
2024
Q3 | $20.5M | Buy |
244,668
+8,107
| +3% | +$619K | 0.15% | 120 |
|
|
2024
Q2 | $16.2M | Buy |
236,561
+6,767
| +3% | +$452K | 0.13% | 128 |
|
|
2024
Q1 | $16.8M | Buy |
229,794
+7,526
| +3% | +$579K | 0.14% | 131 |
|
|
2023
Q4 | $18M | Sell |
222,268
-30,210
| -12% | -$2.35M | 0.16% | 110 |
|
|
2023
Q3 | $18.9M | Buy |
252,478
+13,511
| +6% | +$1.04M | 0.21% | 100 |
|
|
2023
Q2 | $18.4M | Hold |
238,967
| – | – | 0.22% | 99 |
|
|
2023
Q1 | $19.8M | Buy |
238,967
+1,433
| +0.6% | +$119K | 0.27% | 79 |
|
|
2022
Q4 | $20.4M | Buy |
237,534
+28,526
| +14% | +$2.26M | 0.29% | 76 |
|
|
2022
Q3 | $12.9M | Sell |
209,008
-84,730
| -29% | -$5.34M | 0.19% | 118 |
|
|
2022
Q2 | $18.2M | Sell |
293,738
-178,672
| -38% | -$11.1M | 0.18% | 119 |
|
|
2022
Q1 | $28.1M | Buy |
472,410
+24,792
| +6% | +$1.58M | 0.23% | 90 |
|
|
2021
Q4 | $32.5M | Hold |
447,618
| – | – | 0.25% | 89 |
|
|
2021
Q3 | $31.3M | Buy |
447,618
+198,688
| +80% | +$14M | 0.26% | 87 |
|
|
2021
Q2 | $17.1M | Hold |
248,930
| – | – | 0.14% | 125 |
|
|
2021
Q1 | $16.1M | Hold |
248,930
| – | – | 0.14% | 125 |
|
|
2020
Q4 | $14.5M | Buy |
248,930
+14,600
| +6% | +$881K | 0.13% | 125 |
|
|
2020
Q3 | $14.8M | Hold |
234,330
| – | – | 0.14% | 120 |
|
|
2020
Q2 | $18M | Buy |
+234,330
| New | +$18M | 0.19% | 99 |
|
|
2015
Q3 | – | Sell |
-408,000
| Closed | -$47.8M | – | 147 |
|
|
2015
Q2 | $47.8M | Sell |
408,000
-317,000
| -44% | -$34.6M | 0.76% | 56 |
|
|
2015
Q1 | $71.1M | Sell |
725,000
-465,000
| -39% | -$47.2M | 1.16% | 41 |
|
|
2014
Q4 | $112M | Sell |
1,190,000
-245,000
| -17% | -$25.3M | 1.84% | 14 |
|
|
2014
Q3 | $153M | Sell |
1,435,000
-585,000
| -29% | -$57.3M | 2.68% | 6 |
|
|
2014
Q2 | $167M | Buy |
2,020,000
+365,000
| +22% | +$28.4M | 2.88% | 4 |
|
|
2014
Q1 | $117M | Hold |
1,655,000
| – | – | 2.12% | 7 |
|
|
2013
Q4 | $123M | Sell |
1,655,000
-255,000
| -13% | -$17.8M | 2.36% | 7 |
|
|
2013
Q3 | $120M | Buy |
1,910,000
+400,000
| +26% | +$23.9M | 2.25% | 4 |
|
|
2013
Q2 | $77.4M | Buy |
+1,510,000
| New | +$78.7M | 1.65% | 17 |
|
Other funds holding GILD
VCM
VPM
USS Investment Management's GILD Position: Q1 2026 in Review
USS Investment Management increased its Gilead Sciences (GILD) stake by 4.1% in Q1 2026, buying an estimated $1.23M and bringing the position to 221,598 shares worth $30.9M. The position accounts for 0.12% of the portfolio, ranked #92.
USS Investment Management first reported a position in GILD in Q2 2013 and has held it in 33 quarters since. The position peaked at $167M in Q2 2014. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.
- USS Investment Management held 221,598 shares of Gilead Sciences worth $30.9M as of Q1 2026.
- USS Investment Management bought 8,786 Gilead Sciences shares in Q1 2026, an estimated $1.23M.
- Gilead Sciences made up 0.12% of USS Investment Management's portfolio in Q1 2026, its #92 holding.
- USS Investment Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 33 quarters since.
- USS Investment Management's Gilead Sciences position peaked at $167M in Q2 2014.
- 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.
Based on USS Investment Management's 13F filing for Q1 2026, filed 24 Apr 2026.